These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 37063459)
21. Strontium ranelate, a promising disease modifying osteoarthritis drug. Han W; Fan S; Bai X; Ding C Expert Opin Investig Drugs; 2017 Mar; 26(3):375-380. PubMed ID: 28092725 [TBL] [Abstract][Full Text] [Related]
22. Quantitative measurement of cartilage morphology in osteoarthritis: current knowledge and future directions. Wirth W; Ladel C; Maschek S; Wisser A; Eckstein F; Roemer F Skeletal Radiol; 2023 Nov; 52(11):2107-2122. PubMed ID: 36380243 [TBL] [Abstract][Full Text] [Related]
23. Osteoarthritis phenotypes and novel therapeutic targets. Van Spil WE; Kubassova O; Boesen M; Bay-Jensen AC; Mobasheri A Biochem Pharmacol; 2019 Jul; 165():41-48. PubMed ID: 30831073 [TBL] [Abstract][Full Text] [Related]
24. Current Models for Development of Disease-Modifying Osteoarthritis Drugs. Makarczyk MJ; Gao Q; He Y; Li Z; Gold MS; Hochberg MC; Bunnell BA; Tuan RS; Goodman SB; Lin H Tissue Eng Part C Methods; 2021 Feb; 27(2):124-138. PubMed ID: 33403944 [TBL] [Abstract][Full Text] [Related]
25. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Verbruggen G; Goemaere S; Veys EM Clin Rheumatol; 2002 Jun; 21(3):231-43. PubMed ID: 12111630 [TBL] [Abstract][Full Text] [Related]
26. Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis. Emrani PS; Katz JN; Kessler CL; Reichmann WM; Wright EA; McAlindon TE; Losina E Osteoarthritis Cartilage; 2008 Aug; 16(8):873-82. PubMed ID: 18280757 [TBL] [Abstract][Full Text] [Related]
27. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics. Oo WM; Yu SP; Daniel MS; Hunter DJ Expert Opin Emerg Drugs; 2018 Dec; 23(4):331-347. PubMed ID: 30415584 [TBL] [Abstract][Full Text] [Related]
29. Osteoarthritis year 2011 in review: imaging in OA--a radiologists' perspective. Hayashi D; Roemer FW; Guermazi A Osteoarthritis Cartilage; 2012 Mar; 20(3):207-14. PubMed ID: 22266236 [TBL] [Abstract][Full Text] [Related]
30. A narrative review of anti-obesity medications for obese patients with osteoarthritis. Oo WM; Mobasheri A; Hunter DJ Expert Opin Pharmacother; 2022 Aug; 23(12):1381-1395. PubMed ID: 35855642 [TBL] [Abstract][Full Text] [Related]
31. Imaging of osteoarthritis (OA): What is new? Mathiessen A; Cimmino MA; Hammer HB; Haugen IK; Iagnocco A; Conaghan PG Best Pract Res Clin Rheumatol; 2016 Aug; 30(4):653-669. PubMed ID: 27931960 [TBL] [Abstract][Full Text] [Related]
32. Imaging of osteoarthritis: update from a radiological perspective. Guermazi A; Roemer FW; Hayashi D Curr Opin Rheumatol; 2011 Sep; 23(5):484-91. PubMed ID: 21760511 [TBL] [Abstract][Full Text] [Related]
33. The role of imaging in osteoarthritis. Roemer FW; Eckstein F; Hayashi D; Guermazi A Best Pract Res Clin Rheumatol; 2014 Feb; 28(1):31-60. PubMed ID: 24792944 [TBL] [Abstract][Full Text] [Related]
34. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Conaghan PG; Hunter DJ; Maillefert JF; Reichmann WM; Losina E Osteoarthritis Cartilage; 2011 May; 19(5):606-10. PubMed ID: 21396466 [TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging assessment of knee osteoarthritis: current and developing new concepts and techniques. Hayashi D; Roemer FW; Guermazi A Clin Exp Rheumatol; 2019; 37 Suppl 120(5):88-95. PubMed ID: 31621571 [TBL] [Abstract][Full Text] [Related]
36. Role of imaging for eligibility and safety of a-NGF clinical trials. Roemer FW; Hochberg MC; Carrino JA; Kompel AJ; Diaz L; Hayashi D; Crema MD; Guermazi A Ther Adv Musculoskelet Dis; 2023; 15():1759720X231171768. PubMed ID: 37284331 [TBL] [Abstract][Full Text] [Related]
37. Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: the doxycycline trial. Brandt KD; Mazzuca SA Rheum Dis Clin North Am; 2006 Feb; 32(1):217-34, xi-xii. PubMed ID: 16504832 [TBL] [Abstract][Full Text] [Related]
38. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Verbruggen G; Goemaere S; Veys EM Osteoarthritis Cartilage; 1998 May; 6 Suppl A():37-8. PubMed ID: 9743818 [TBL] [Abstract][Full Text] [Related]
39. Neuropathic pain in the IMI-APPROACH knee osteoarthritis cohort: prevalence and phenotyping. van Helvoort EM; Welsing PMJ; Jansen MP; Gielis WP; Loef M; Kloppenburg M; Blanco F; Haugen IK; Berenbaum F; Bay-Jensen AC; Ladel C; Lalande A; Larkin J; Loughlin J; Mobasheri A; Weinans H; Lafeber F; Eijkelkamp N; Mastbergen S RMD Open; 2021 Dec; 7(3):. PubMed ID: 34911812 [TBL] [Abstract][Full Text] [Related]
40. Use magnetic resonance imaging to assess articular cartilage. Wang Y; Wluka AE; Jones G; Ding C; Cicuttini FM Ther Adv Musculoskelet Dis; 2012 Apr; 4(2):77-97. PubMed ID: 22870497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]